Deficient wound healing in diabetic patients is very frequent, but the cellular and molecular causes are poorly defined. In this study, we evaluate the hypothesis that high glucose concentrations inhibit cell migration. Using CHO.K1 cells, NIH-3T3 fibroblasts, mouse embryonic fibroblasts and primary skin fibroblasts from control and diabetic rats cultured in 5 mM D-glucose (low glucose, LG), 25 mM D-glucose (high glucose, HG) or 25 mM L-glucose medium (osmotic control - OC), we analyzed the migration speed, protrusion stability, cell polarity, adhesion maturation and the activity of the small Rho GTPase Rac1. We also analyzed the effects of reactive oxygen species by incubating cells with the antioxidant N-Acetyl-Cysteine (NAC). We observed that HG conditions inhibited cell migration when compared to LG or OC. This inhibition resulted from impaired cell polarity, protrusion destabilization and inhibition of adhesion maturation. Conversely, Rac1 activity, which promotes protrusion and blocks adhesion maturation, was increased in HG conditions, thus providing a mechanistic basis for the HG phenotype. Most of the HG effects were partially or completely rescued by treatment with NAC. These findings demonstrate that HG impairs cell migration due to an increase in oxidative stress that causes polarity loss, deficient adhesion and protrusion. These alterations arise, in large part, from increased Rac1 activity and may contribute to the poor wound healing observed in diabetic patients.
Citation: Lamers ML, Almeida MES, Vicente-Manzanares M, Horwitz AF, Santos MF (2011) High Glucose-Mediated Oxidative Stress Impairs Cell Migration. PLoS ONE 6(8): e22865. https://doi.org/10.1371/journal.pone.0022865
Editor: Mikhail V. Blagosklonny, Roswell Park Cancer Institute, United States of America
Received: May 11, 2011; Accepted: June 30, 2011; Published: August 3, 2011
Copyright: © 2011 Lamers et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by the following agencies/grants: NIH (GM23244), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES (#5181062), Fundação de Amparo à Pesquisa do Estado de São Paulo - FAPESP (06/57508-2), Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq (478606/2010-9; 480092/2010-9), Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul - FAPERGS (0903698). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Diabetes mellitus is a group of metabolic disorders that cause chronic hyperglycemia and is one of the most significant diseases in the developed world, affecting more than 170 million people. The tissue responses to diabetic conditions are varied; many are associated with oxidative stress in the cells . The improper management of hyperglycemia leads to severe complications in diabetic patients: approximately 15% of patients display impaired wound healing, causing long-term complications such as limb amputation .
Skin wound repair involves a series of coordinated processes that include cell proliferation and migration, collagen deposition and remodeling, wound contraction, and angiogenesis. These processes involve different cell types, mostly fibroblasts/myofibroblasts, keratinocytes, and endothelial cells , . While hyperglycemia has been linked to impaired wound healing, particularly altered angiogenesis and extracellular matrix remodeling , the nature of the linkage is unclear. Some studies have described alterations in cell migration associated with diabetic conditions. For example, Lerman et al.  showed that fibroblasts from diabetic mice migrate 75% less than those from normoglycemic mice and display a defective response to hypoxia, a condition commonly present in chronic wounds. A similar inhibition was recently observed in keratinocytes cultured in a high glucose environment , which suggests that high glucose plays a direct role on cell migration. However, none of these studies addressed the cellular mechanism by which this happens.
The migratory process is a cycle comprised of distinct, integrated steps that are regulated by the activation of signaling molecules. These steps are: polarization, in which the cell develops a clear front and rear; protrusion, which is driven by actin polymerization at the leading edge; the formation of substrate adhesions that serve to stabilize protrusions and generate the dynamic signaling, which converge on Rho GTPases. The cycle is completed with retraction at the cell rear and the release of adhesions –. The small Rho GTPases are central regulators that integrate and drive these processes; they act through several effector proteins that mediate migration. For example, Rac1 regulates the formation of the lamellipodium and adhesion dynamics, while RhoA is involved in the formation of actin bundles and adhesion maturation .
This study addresses the mechanism by which high glucose inhibits cell migration. We characterized the effect of an acute high glucose treatment on several migration-related parameters that define the steps of cell migration in different cultured cell types, including CHO.K1, NIH-3T3, mouse embryonic fibroblasts (MEFs). We have also used primary skin fibroblasts obtained from control and diabetic rats. We observed that high glucose increased reactive oxygen species (ROS) production, impaired cell polarization, decreased migration speed, protrusion persistence and stability, and adhesion maturation. These effects point to the Rho GTPases as mediators of these effects. In this regard, we observed a significant increase in the activation of the small GTPase Rac1, which is inhibited by antioxidants. Consistently, antioxidants reverted most of the migratory effects caused by high glucose. Together, our data indicates that hyperglycemia impairs cell migration through increased generation of ROS, which induces an abnormal activation of Rac1.
High glucose decreases migration speed and directionality
To determine the effects of high glucose treatment on cell migration, we treated CHO.K1, NIH-3T3 fibroblasts or mouse embryonic fibroblasts (MEF) with LG (low glucose), HG (high glucose) or OC (osmotic control) media for 3 days. We then plated the cells on 2 µg/ml fibronectin, which promotes cell migration , and imaged them using time-lapse microscopy. Acute treatment with HG decreased the migration speed by ∼40% compared to LG or OC cells (Figure 1A) (p<0.01, n = 50 cells). These effects are time-dependent; MEF migration was decreased by ∼60% after 10 days of treatment with HG medium compared to LG medium (Figure 1B, p<0.01, n = 20 cells). Similar results were obtained with primary fibroblasts from control and diabetic rats (Figure 1C, p<0.01, n = 20 cells). The decrease in migration speed caused by HG was also accompanied by a decrease in cell directionality, which likely contributes to the migration impairment (Figure S1). The fact that the OC group showed almost no effect on cell migration suggests that glucose internalization and metabolism are necessary for this effect on the migratory process.
A: Effects of 3 days treatment with low glucose (LG), high glucose (HG) or osmotic control (OC) medium on migration speed of CHO.K1, NIH-3T3 and MEF cells from at least 4 independent experiments. B: Effects of 3, 5 or 10 days with LG or HG medium on migration speed of MEF cells from at least 3 experiments. C: Migration speed of primary skin fibroblasts from control and diabetic rats. Results are shown as the % of the control (LG) ± SEM. (*) P≤0.01 according to Student's t test or One-way analysis of variance (ANOVA) followed by Tukey's post-test.
High glucose increases the number of cell protrusions but decreases their stability
To study the mechanism underlying the observed decrease in migration caused by HG conditions, we addressed the effect of high glucose on protrusion and adhesion. Using time-lapse imaging, we observed that HG medium induced a threefold increase in the number of CHO.K1 cells displaying more than three protrusions compared to the LG and the OC groups (Figure 2A, 2B and 2C, Movies S1 and S2). This behavior was also observed with the NIH-3T3 cells (100% increase, data not shown) and, to a lower extent, in primary rat fibroblasts (60% increase, Figure 2D).
Photomicrographs show changes in CHO.K1 cell protrusions (arrows) within 7, 15, 22 and 30 minutes in cells cultured under control (A) and high glucose (B) conditions. C: Shows the percentage of CHO.K1 cells with more than 3 protrusions over a 30 minutes period in low glucose (LG), high glucose (HG) or osmotic control (OC) medium and in the presence or absence of the antioxidant N-acetylcysteine (NAC, 10 mM) for 1 hour. D: Shows the percentage of primary skin fibroblasts of control and diabetic rats with more than 2 protrusions over a 30 minutes period. E: Kymograph showing the extension of a protrusion over time. F: Kymographs of LG and (G) HG treated CHO.K1 cells, showing that protrusions under high glucose treatment are less stable and retract, followed by the formation of new protrusions at the same places. H: shows the percentage of lamellipodia that retract over a 30 min period in CHO.K1, NIH-3T3 and MEF cells and (I) shows the same for primary skin fibroblasts from control and diabetic rats. Bar: 10 µm.
A large fraction of the HG-induced protrusions appeared unstable, i.e. exhibited brief cycles of quick extension and retraction, and increased ruffling. To quantify this, we analyzed the protrusions by generating kymographs (Figure 2E) . These revealed that most of the protrusions of the LG and OC-treated cells exhibited a homogenous behavior, defined by a period of linear and persistent progression followed by a period of quiescence (Figure 2F). Only a small fraction of these protrusions showed retraction (Figure 2H). Conversely, in the HG group, the protrusions also extended forward and became quiescent, but the quiescent periods were much shorter and in 50% of the protrusions, followed by intense retraction (Figure 2H). In many cases, the cycle repeated more than once in a particular region of the cell (Figure 2G). We observed a modest but significant increase in the protrusion rates of 3T3-NIH and MEF cells (data not shown). Skin fibroblasts from diabetic rats displayed a similar behavior, i.e., a 4-fold increase in retraction frequency when compared to control fibroblasts (Figure 2I). These data suggest that high glucose treatment leads to an increase in the number of non-productive protrusive events in the cell.
High glucose decreases adhesion maturation
The relationship between protrusion stability and adhesion suggested that the observed alterations in protrusion might arise from defects in adhesion , . To test this hypothesis, we expressed paxillin-GFP in cells in the LG and HG groups, and imaged their behavior when plated on fibronectin using total internal reflection microscopy (TIRF). LG medium promoted the formation of large, elongated adhesions, in approximately 55% of the adhesions present at the leading edge of CHO.K1 cells (Figure 3B and 3C, Movie S3). In contrast, only 25% of the adhesions in cells from the HG group underwent maturation (Figure 3A and 3C, Movie S4). These data suggest that decreased adhesion contributes to the observed protrusion instability in the HG group.
After 2 days treatment, cells were transfected with GFP-paxillin and their adhesion dynamics analyzed 24 h later using TIRF microscopy. The increase in adhesion size and fluorescence intensity were considered signs of maturation (arrows). Time-lapse sequences show adhesions maturation of (A) high glucose (HG) and (B) Low glucose (LG) treated cells. C: The graph shows the probability of adhesion maturation of LG or HG treated cells, in the presence or absence of 10 mM N-acetylcysteine (NAC) for 1 hour, using at least 10 cells for each condition. Bar: 5 µm. (*) P≤0.01.
High glucose activates the small GTPases Rac1 and RhoA
Adhesion and protrusion are regulated by the Rho GTPases. Rac1 induces lamellipodial protrusion and adhesion formation, while RhoA mediates adhesion maturation and edge retraction , , . To determine whether these GTPases underlie the observed effects of HG treatment in protrusion and adhesion, we determined the activation state of RhoA and Rac1 using an affinity pull-down system . Both CHO.K1 and NIH-3T3 cells showed a moderate, but reproducible (40%), increase in GTP-bound (active) Rac1 compared to LG cells (Figure 4A, p<0.05, n = 5). HG also increased activated RhoA (Figure 4B, p<0.05, n = 3). Interestingly, increased osmolarity also increased RhoA, but not Rac1 (Figure 4B, p<0.05, n = 3). These results indicate that HG conditions promote activation of Rac1 due to a specific effect related to the glucose metabolism and not a mechanical effect caused by osmotic stress, which can, however, activate RhoA.
Representative western blotting showing the results of a pull-down assay for Rac1 activation and total Rac1 (A), as well as for RhoA activation and total RhoA (B) in control (LG), high glucose (HG) and osmotic control (OC), in the presence or absence of 10 mM N-acetylcysteine (NAC) for 1 hour. The ratio between activated and total proteins was measured by densitometry. Protein bands shown are representative of the experiments, and the results from 4 independent experiments were expressed as percentage of the control (LG) ± SEM. (*) P≤0.05 according to one-way analysis of variance (ANOVA) followed by Tukey's post-test.
High glucose alters cell polarity
Altered GTPase activation often leads to aberrant cell morphologies. High Rac1 activation, in particular, can lead to large, round cells without a clear front and back . To determine the effect of HG leads on cell polarity, we analyzed over >600 cells treated with each condition. We used a polarity index (PI), which is the length of a cell in the direction of migration (migratory axis) divided by its width orthogonal to the migration axis passing through the center of the nucleus (transverse axis) (Figure 5A). Most of the CHO.K1 cells of the LG and OC groups were elongated (Figures 5B and 5D, 2.5<PI<3.5; 49% (LG) and 44% (OC) of the cell population) or very elongated [index PI>3.5; 27% (LG) and 31% (OC)] with only a small percentage round [PI<2; 24% (LG) and 25% (OC)]. In contrast, the HG group (Figure 5C), showed a large decrease in the fraction of highly elongated cells and an increase in the fraction of round cells [41% of the cells displayed a round shape (PI<2), 44% an elongated shape (2.5<PI<3.5), and only 14% a very elongated shape (PI>3.5)]. This suggests that acute HG treatment induces loss of cell polarization, which is consistent with the increased activity of Rac1 and the projection of multiple lamellipodia observed in these conditions.
A: The picture shows the two axes used for the polarity index calculation, with an example of a low polarized (left) and a highly polarized cell (right). The histograms show the distribution of cells cultivated with low glucose (B), high glucose (C), osmotic control (D), low glucose +10 mM N-acetyl-cysteine (NAC) for 1 h (E) and HG +10 mM NAC for 1 h (F), regarding polarity.
Diabetes increases ROS generation
Increased ROS generation is a hallmark of diabetes. To establish that high glucose increases ROS production in our system, we used an assay for ROS, using a fluorescence method, in cells treated for 3 days with LG or HG medium, both in the presence or absence of N-acetyl-cysteine (NAC, 10 mM, 1 h) , an antioxidant. Cells in HG medium exhibited a twofold increase in ROS compared to the LG and OC groups (Figure 6K); this increase was abolished by NAC treatment. Confocal microscopy confirmed the increase in ROS levels induced by HG treatment (Figure 6B and 6F); interestingly, most of the ROS localized to the cell body and protrusions, and both compartments exhibited elevated levels of ROS compared to the control groups (Figure 6A and 6E).
The probe 2′,7′-dichlorohydrofluorescein (DCFH2-DA) was employed in low glucose (LG) cells (A, E), high glucose (HG) cells (B, F), LG cells in the presence of 10 mM N-acetyl-cysteine (NAC) for 1 h (C, G), and HG cells in the presence of 10 mM NAC for 1 h (D, H). The negative control consisted of cells not exposed to the probe (I), while the positive control consisted of cells exposed to 10 µM H2O2 for 10 min (J). ROS were observed throughout the cell body and in cell protrusions, especially in high glucose-treated cells. K: Measurement of ROS using fluorimeter. OC = osmotic control. Results were expressed as percentage of the control (LG) ± SEM. (*) P≤0.01 using one-way analysis of variance (ANOVA) followed by Tukey's post-test. Bar: 10 µm.
Glucose uptake and metabolism renders the cell more susceptible to increased ROS generation. Therefore, we assessed glucose metabolism in primary skin fibroblast cultures, and observed that cells from diabetic rats had a 40% increase in the expression of the glucose transporter GLUT1 (Figure S2A), which was also accompanied by a similar increase in glucose entrance into the glycolytic pathway (>40% increase on Hexokinase activity) and metabolism (35% increase on Pyruvate Kinase activity) (Figures S2B and S2C). Lactate dehydrogenase activity was not affected, suggesting that the increased glucose metabolism was mostly aerobic (Figure S2D).
Decrease of ROS in HG cells improves migratory parameters
We then asked whether high glucose metabolism impairs cell migration through its effect on ROS generation. Treatment with NAC completely rescued the effect of HG medium on the number of protrusions per cell, reaching values similar to those obtained with LG or OC treatment (Figure 2C). Adhesion maturation in HG cells was also restored by NAC (Figure 3C). In addition, NAC also blocked the effect of high glucose on Rac1 activation (Figure 4A, p<0.05, n = 5). Interestingly, NAC did not inhibit the increase in RhoA activation; furthermore, it increased the degree of RhoA activation by 2-fold, even in LG cells (Figure 4B, p<0.01, n = 3). Finally, the depolarizing effect of HG treatment was also rescued by NAC (Figure 5F); importantly, NAC treatment had no effect on control cells (Figure 5E). This data indicates that ROS generation is involved in the inhibition of cell migration observed with HG treatment through a mechanism that involves the activation of Rac1 and its balance with the activation of RhoA.
Our data show that increased glucose uptake by fibroblasts inhibits cell migration through inadequate activation of the small GTPase Rac1, which depends on the oxidative state of the cell. Intracellular glucose is metabolized through a series of enzymatic reactions that are optimized by molecular oxygen and electron transport, which provides energy for ATP generation; ROS are byproducts of this process. There is strong evidence that excessive glucose increases ROS formation , , , which in turn overcomes the antioxidant capacity of the cell (oxidative stress). This has deleterious effects, including the non-specific oxidation of proteins and lipids, alterations in gene expression and perturbations of different signaling pathways , . Our results indicate that ROS generation decreases cell migration by over-activation of the small Rho GTPase Rac1. ROS generation and Rac1 activation are therefore part of a positive feedback loop, as Rac1 increases ROS generation by activating the NADPH oxidase system . Furthermore, activation of Rac1 by a specific guanine-nucleotide-exchange factor suffices to induce glucose uptake into skeletal-muscle cells , thereby contributing to its own glucose- and ROS-dependent activation.
In migrating cells, Rac1 is activated near the leading edge and is thought to drive protrusion , . Therefore, the local activation of Rac1 near the leading edge may generate a local increase of ROS in this cellular region that oxidizes cysteine residues in different redox-sensitive targets , including signaling adaptors that can modulate the activation of small GTPases such as Rac1 or RhoA , . On the other hand, sustained oxidative stress may affect these proteins differently, due to excessive oxidation . Interestingly, increased Rac1 activity was also observed in cardiac fibroblasts from diabetic mice  and in endothelial cells . Furthermore, inhibition of either Rac1 or NADPH oxidase activity protected from vascular injury in this system , . Our data strongly suggest that most of the cellular effects of HG are due to a modest increase in Rac1 activation, which is in agreement with other studies that have shown that moderate Rac1 activation is sufficient to decrease migration speed and directionality, as well as to promote an increase in the number of protrusions per cell . However, the increased Rac1 activity may lead to its mislocalization, which would amply the effect.
Our data also shows that HG increases RhoA activity. Rac1 and RhoA are reciprocally regulated by a negative feedback loop , , which may implicate NAPDH oxidase , . However, the increase in RhoA activity is not specifically dependent on the glucose metabolism, since the osmotic control also displayed similar increase. Osmotic pressure applies mechanical stress to the cellular cortex, which may contribute to this activation similar to mechanical tension which, applied to the cell membrane, increases RhoA activation , bypassing the requirement of low Rac activity and thus breaking down the Rac-RhoA feedback loop. However, RhoA is also associated to the deleterious effects of diabetes, particularly in mesangial cells , , as well as in several organs that are targeted by diabetes –.
The crosstalk between Rho GTPases and other pathways under HG conditions cannot be ruled out. For example, the inhibition of the nutrient-sensing mammalian target of rapamycin (mTOR) pathway inhibits RhoA and Rac1 activity, affecting cell motility . This pathway is activated by glucose and, in several cell types (including fibroblasts), its activation is required for acquiring a senescent phenotype , . One of the phenotypical alterations promoted by HG in fibroblasts was an increased cell size (Fig. 2), which is also observed in senescent cells, due to hypertrophy . Interestingly, there is a positive feedback between the TOR pathway and ROS generation. ROS are generated in mitochondria in response to glucose, stimulating the mTOR pathway . TOR signaling, on the other hand, may regulate mitochondrial proteome dynamics; it was shown that reduced TOR signaling increases mitochondrial oxygen consumption and decreases ROS generation . Thus, the effect of NAC reversing the HG phenotype might be at least partially related to the inhibition of the mTOR pathway.
In summary, this study provides novel mechanistic insight into the effects of high glucose on cell migration, which is a likely contributor to the defects in wound healing often observed in diabetic patients. Our results provide a mechanistic framework, i.e. increased Rac1 activation, that explains previous observations.
Materials and Methods
Animals and primary cell culture preparation
All experiments were conducted in accordance to the NIH guidelines, and the protocols were approved by the Biomedical Sciences Institute/University of São Paulo Ethical Committee for Animal Research (2005, n109, fl10, lv2). Adult male Wistar rats were maintained in individual cages, with food and water available ad libitum. Six rats were used, with the same weight, equally divided in control and experimental groups. After a 12 h fasting, the experimental group was injected with streptozotocin (60 mg/kg body weight in 0.05 M citrate buffer, pH 4.5), while the control group received only the vehicle. Glycaemia was measured 24 h later and at the moment of the sacrifice, using Accu-Check® (Roche Diagnostics) and only animals with glycaemia higher than 300 mg/dl were considered diabetic. The body weight, food intake, blood glucose and urine volume were measured periodically. The glucose content in urine was also measured using Glucose HK Liquiform® (Labtest, Sete Lagoas, MG, Brazil). After 30 days, the animals were sacrificed with an overdose of ketamine and xylazine. All animals of the experimental group showed significant alterations in physiological parameters such as body weight, glycaemia and glycosury, confirming the diabetic state. When compared to the control group, diabetic animals did not gain weight and showed hyperphagia, high levels of blood glucose and glycosury (Table S1).
Cell culture, conditions and transfection
CHO.K1 and NIH-3T3 cells were obtained from American Type Culture Collection (ATCC, Manassas, VA) while MEF were obtained at Gene Targeting and Transgenic Facility at University of Virginia (Charlottesville, VA). The cells were cultured under standard conditions, with DMEM low glucose medium (5 mM D-glucose) containing 10% fetal bovine serum (FBS), 100 U/ml penicillin and 1% non-essential amino acids (NEAA). For the primary skin fibroblast culture of control and diabetic animals, a 6 cm2 skin area was washed in PBS and the dermis was scraped and enzymatically digested with type I collagenase (0.1%) for 1 hour at 37°C under gentle agitation. After the addition of 5 ml FBS the cell suspension was centrifuged at 400 rpm for 10 min. The pellet was transferred to a Petri dish containing DMEM low glucose medium (for control fibroblasts) or DMEM high glucose medium (for diabetic fibroblasts), both containing 10% FBS, 100 U/ml penicillin, 1% NEAA and 2.5 µg/ml fungizone. The medium was changed thrice a week and cells were trypsinized at 80% confluence. Passages 5–8 were used for the cell migration experiments.
Cells were cultured for 3, 5, or 10 days in DMEM medium containing 5 mM D-glucose (low glucose - LG), 25 mM D-glucose (high glucose - HG), or 25 mM L-glucose (OC). When used, N-acetylcysteine at 10 mM was added for 1 h prior to the experiments. For GTPase activation assays, cells were cultured for 3 days in the designated serum-deprived (0.5% FBS) medium for 12 h and then stimulated with complete medium for 1 h before the experiments. The cells were transfected with the paxillin-GFP plasmid  using Lipofectamine (Invitrogen, Eugene, OR) following the manufacturer's instructions. The reagents for cell culture were purchased from Gibco (Invitrogen, Eugene, OR), while the chemicals were purchased from Sigma (St Louis, MO).
Primary dermal fibroblasts were cultured in LG or HG medium, trypsinized, centrifuged and lysed with 100 µl of buffer containing Imidazol (50 mM, pH 7.2 at 4°C); the lysate was submitted to centrifugation and enzymatic activity was measured in the supernatant. For the Hexokinase (HK) activity, 20 µl of the supernatant were added to a buffer containing 50 mM Imidazol (pH 7.2), 5 mM MgCl2, 5 mM ATP, 1 mM glucose, 0.4 mM NADP and 0.3 U glucose-6-phosphate dehydrogenase; for the Pyruvate Kinase (PK) activity, 20 µl of the supernatant were added to a buffer containing 50 mM Imidazol (pH 7.2), 5 mmol/l MgCl2, 0.1 mol/l KCl, 1 mmol/l ADP, 0.15 mmol/l NADH, 2 mmol/l phosphoenolpyruvate and 0.9 U lactate dehydrogenase; for the Lactate Dehydrogenase (LDH) activity the supernatant was incubated with phosphate/pyruvate (50.0 mM) buffer for 5 min followed by the addition of 11.3 mM NADH. The reactions were monitored by changes in the absorption at 340 nm wavelength for 10 min at 30°C using a spectrophotometer (Beckman DU-68 Beckman, Fullerton, CA); HK and PK activities were analyzed due to the formation of NADPH and LDH activity by the rate of NADH oxidation. One unit (U) of enzyme activity corresponds to the amount of enzyme that converts 1 µmol of substrate per min. The results were normalized to the amount of protein presented in the supernatant and expressed as U/mg protein. All the chemicals were purchased from Sigma (St. Louis, MO, USA).
Microscopy and image processing
Cells were plated on fibronectin–coated glass-bottomed dishes (2 µg/ml for CHO.K1 and 1 µg/ml for NIH-3T3, MEF and primary fibroblasts) in CCM1 medium for 1 h and maintained at 37°C at pH 7.4 (migration promoting conditions). For phase microscopy, time-lapse images were captured at 10 min intervals (0.25 NA CFI Achro DL10× Nikon objective) with a charge-coupled device camera (Orca II; Hamamatsu Photonics, Iwata-City, Japan) attached to an inverted microscope (TE-300; Nikon, Tokyo, Japan) using Metamorph software (Universal Imaging Corp., Downingtown, PA).
Confocal images were collected on an Olympus FluoView 300 system (1.45 NA oil PlanApo 60× TIRFM objective). GFP was excited using the 488 nm laser line of an Argon laser (Melles Griot, Albuquerque, NM). A Q500LP dichroic mirror (Chroma Technology Corp. Rockingham, VT) and a HQ525/50 emission filter was used for GFP labeled cells. Fluorescence images were acquired using FluoView software (Olympus, Tokyo, Japan).
TIRF images were acquired in an Olympus IX70, inverted microscope (1.45 NA oil Olympus PlanApo ×60 TIRFM objective) fitted with a Ludl modular automation controller (Ludl Eletronic Products, Howthorne, NY) and controlled by Metamorph (Molecular Devices). GFP was excited using the 488 nm laser line of an Ar ion laser (Melles Griot). Also, a dichroic mirror (HQ485/30) and a HQ525/50 emission filter were used. All Images were acquired with a charge-coupled device camera (Retiga Exi; Qimaging, Surrey, Canada) and analyzed using ImageJ software (http://rsbweb.nih.gov/ij).
For kymography, images were captured every 5 s for 30 min (0.65 NA CFI Achro DL 40× Nikon objective). A line (5 pixels-wide) was drawn along regions oriented in the protrusion direction and perpendicular to the lamellipodial edge. Protrusion parameters were quantified by kymography , using Image J software. The results were plotted in a graph where the Y axis is the distance reached by the lamellipodium along that line, and the X axis is time.
Rho and Rac activation assay
Pull-down assays for activated Rac1 and RhoA were performed as described previously . Briefly, after overnight serum starvation, the cells were stimulated with serum for 1 h, washed and lysed in CRIB buffer containing 1% NP-40, 50 mM Tris pH 7.4, 10% glycerol, 100 mM NaCl, 2 mM MgCl2, a protease inhibitor cocktail (Sigma P8340) and 20 µg of recombinant GST–PBD (Rac1) or GST-Rhotekin (RhoA). Cell lysates were then incubated with glutathione–agarose beads (Pharmacia, Stockholm, Sweden) for 30 min at 4°C, washed with lysis buffer and eluted with SDS sample buffer. Bound Rac1 and RhoA were analyzed by Western blotting. Whole-cell lysates were also analyzed for the presence of Rac1 and RhoA for normalization.
Samples were submitted to SDS-PAGE with 15% gels and transferred to a PDVF membrane. Deffated milk or 5% BSA in PBS/0.5% Tween 20 were used for blocking during 45 min at room temperature. Incubation with the primary antibodies anti-Rac1 (1∶1000, BD Biosciences, Franklin Lakes, NJ), anti-RhoA (1∶500, Santa Cruz Biotech, Santa Cruz, CA) or anti-GLUT1 (1∶1000, Abcam, Cambridge, MA) was performed overnight at 4°C. After washing, membranes were incubated with peroxidase-conjugated secondary antibody (Amersham Pharmacia Biotech., Chalfont St. Gilles, United Kingdom), and the reaction was detected by chemioluminescence (Pierce, Thermo, Rockford, IL).
Detection of Reactive Oxygen Species (ROS)
Cells were cultured for 3 days with the specified medium, trypsinized, washed and incubated with 10 µM 5–6-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA, Invitrogen, Eugene, OR) for 15 min. Cells were lysed, centrifuged (1 min, 13000 rpm at 4°C), the supernatant was analyzed by fluorimetry (excitation 492 nm and emission 525 nm, Fluorocount Packard, Perkin Elmer, Walthan, MA), and the protein concentration quantified. As positive control the cells were incubated with 100 µM H2O2, and the probe was omitted for the negative control. Results were calculated by mg/protein and expressed as % of control. For ROS visualization, cells were plated on 2 µg/ml fibronectin-coated glass-bottomed dishes, incubated using the same method described above, and then viewed on the confocal microscope.
Assessment of cell polarity
For assessment of cell polarity, the polarity index was calculated as the length of the major migration axis (parallel to the direction of movement) divided by the length of the perpendicular axis that intersects the center of the cell nucleus.
Migration of CHO.K1 cells cultured under low glucose (LG), high glucose (HG), and in osmotic control (OC) medium. Due to the lower rate and directionality, the distances traveled by HG cells are shorter when compared to the controls. Individual cell trajectories starting at the same point are shown: the shorter distances (<30 radials) in red, intermediate distances (30–60 radials) in blue, and longer distances (>60 radials) in black. The lower graph (B) shows the distribution of cells in each category.
Diabetes increases glucose metabolism in dermal fibroblasts. Expression of the glucose transporter GLUT1 (A) and the activities of the glycolytic pathway enzymes Hexokinase (B), Pyruvate kinase (C) and Lactate Dehydrogenase (D) in primary skin fibroblasts of control and diabetic rats. Results were expressed as U/mg of protein and are shown as the % of the control ± SEM, n = 4 animals/group. The enzymatic activities were performed in triplicate. Proteins bands are representative of the experiment. (*) P≤0.01 according to Student's t test.
Changes in physiological parameters after 30 days of induction of diabetes with streptozotocin.
movie shows protrusions of CHO.K1 cells cultured with low glucose (control) during 3 days and plated under migration promotion conditions. This movie corresponds to Figure 3A. Total time = 30 minutes.
movie shows protrusions of CHO.K1 cells cultured with high glucose during 3 days and plated under migration promotion conditions. Cells produce several instable protrusions in different directions, when compared to control cells (Movie S1). This movie corresponds to Figure 3B. Total time = 30 minutes.
TIRF microscopy of dynamic adhesions of CHO.K1 cells transfected with GFP-paxillin, cultured under low glucose conditions (control). The increase in adhesion size and on fluorescence intensity were considered signs of maturation. This movie corresponds to Figure 4B. Total time = 20 minutes.
TIRF microscopy of dynamic adhesions of CHO.K1 cells transfected with GFP-paxillin, cultured under high glucose conditions. The increase in adhesion size and on fluorescence intensity were considered signs of maturation. Compared to control conditions (Movie S3), the number of mature adhesions in high glucose-treated cells is smaller. This movie corresponds to Figure 4A. Total time = 20 minutes.
The authors thank Jessica Zareno (University of Virginia, VA) for technical assistance and Colin Choi (University of Pennsylvania, PA) for help with the adhesion studies.
Conceived and designed the experiments: MLL MV-M AH MFS. Performed the experiments: MLL MESA. Analyzed the data: MLL. Contributed reagents/materials/analysis tools: MLL AH MFS. Wrote the paper: MLL MV-M AH MFS.
- 1. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813–20.M. Brownlee2001Biochemistry and molecular cell biology of diabetic complications.Nature41481320
- 2. Yach D, Stuckler D, Brownell KD (2006) Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12(1): 62–6.D. YachD. StucklerKD Brownell2006Epidemiologic and economic consequences of the global epidemics of obesity and diabetes.Nat Med121626
- 3. Martin P (1997) Wound healing-aiming for perfect skin regeneration. Science 276: 75–81.P. Martin1997Wound healing-aiming for perfect skin regeneration.Science2767581
- 4. Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and regeneration. Nature 453(7193): 314–21.GC GurtnerS. WernerY. BarrandonMT Longaker2008Wound repair and regeneration.Nature453719331421
- 5. Braiman-Wiksman L, Solomonik I, Spira R, Tennenbaum T (2007) Novel insights into wound healing sequence of events. Toxicol Pathol 35: 767–79.L. Braiman-WiksmanI. SolomonikR. SpiraT. Tennenbaum2007Novel insights into wound healing sequence of events.Toxicol Pathol3576779
- 6. Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC (2003) Cellular dysfunction in the diabetic fibroblast: impairment in migration,vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 162: 303–12.OZ LermanRD GalianoM. ArmourJP LevineGC Gurtner2003Cellular dysfunction in the diabetic fibroblast: impairment in migration,vascular endothelial growth factor production, and response to hypoxia.Am J Pathol16230312
- 7. Lan CC, Liu IH, Fang AH, Wen CH, Wu CS (2008) Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes. Br J Dermatol 159(5): 1103–15.CC LanIH LiuAH FangCH WenCS Wu2008Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes.Br J Dermatol1595110315
- 8. Lauffenburger DA, Horwitz AF (1996) Cell migration: a physically integrated molecular process. Cell 84: 359–69.DA LauffenburgerAF Horwitz1996Cell migration: a physically integrated molecular process.Cell8435969
- 9. Webb DJ, Parsons JT, Horwitz AF (2002) Adhesion assembly, disassembly and turnover in migrating cells - over and over and over again. Nat Cell Biol 4: 97–100.DJ WebbJT ParsonsAF Horwitz2002Adhesion assembly, disassembly and turnover in migrating cells - over and over and over again.Nat Cell Biol497100
- 10. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, et al. (2003) Cell migration: integrating signals from front to back. Science 302(5651): 1704–9.AJ RidleyMA SchwartzK. BurridgeRA FirtelMH Ginsberg2003Cell migration: integrating signals from front to back.Science302565117049
- 11. Parsons JT, Horwitz AR, Schwartz MA (2010) Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 11(9): 633–43.JT ParsonsAR HorwitzMA Schwartz2010Cell adhesion: integrating cytoskeletal dynamics and cellular tension.Nat Rev Mol Cell Biol11963343
- 12. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, et al. (2004) FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6(2): 154–61.DJ WebbK. DonaisLA WhitmoreSM ThomasCE Turner2004FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly.Nat Cell Biol6215461
- 13. Hinz B, Alt W, Johnen C, Herzog V, Kaiser HW (1999) Quantifying lamella dynamics of cultured cells by SACED, a new computer-assisted motion analysis. Exp Cell Res 251(1): 234–43.B. HinzW. AltC. JohnenV. HerzogHW Kaiser1999Quantifying lamella dynamics of cultured cells by SACED, a new computer-assisted motion analysis.Exp Cell Res251123443
- 14. Ridley AJ, Hall A (1992) The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389–99.AJ RidleyA. Hall1992The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.Cell7038999
- 15. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A (1992) The small GTP-binding protein Rac regulates growth factor-induced membrane ruffling. Cell 70: 401–10.AJ RidleyHF PatersonCL JohnstonD. DiekmannA. Hall1992The small GTP-binding protein Rac regulates growth factor-induced membrane ruffling.Cell7040110
- 16. Chrzanowska-Wodnicka M, Burridge K (1996) Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 133(6): 1403–15.M. Chrzanowska-WodnickaK. Burridge1996Rho-stimulated contractility drives the formation of stress fibers and focal adhesions.J Cell Biol1336140315
- 17. Sanders DA (1990) A guide to low molecular weight GTPases. Cell Growth Differ 1(5): 251–8.DA Sanders1990A guide to low molecular weight GTPases.Cell Growth Differ152518
- 18. Aruoma OI, Halliwell B, Hoey BM, Butler J (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide,hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6: 593–7.OI AruomaB. HalliwellBM HoeyJ. Butler1989The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide,hydroxyl radical, superoxide, and hypochlorous acid.Free Radic Biol Med65937
- 19. Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57: 1446–54.JM ForbesMT CoughlanME Cooper2008Oxidative stress as a major culprit in kidney disease in diabetes.Diabetes57144654
- 20. Paravicini TM, Touyz RM (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31: S170–80.TM ParaviciniRM Touyz2008NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.Diabetes Care31S17080
- 21. Terada LS (2006) Specificity in reactive oxidant signaling: think globally, act locally. J Cell Biol 174(5): 615–23.LS Terada2006Specificity in reactive oxidant signaling: think globally, act locally.J Cell Biol174561523
- 22. Chiarugi P, Buricchi F (2007) Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications. Antioxid Redox Signal 9(1): 1–24.P. ChiarugiF. Buricchi2007Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications.Antioxid Redox Signal91124
- 23. Miyano K, Sumimoto H (2007) Role of the small GTPase Rac in p22phox-dependent NADPH oxidases. Biochimie 89(9): 1133–44.K. MiyanoH. Sumimoto2007Role of the small GTPase Rac in p22phox-dependent NADPH oxidases.Biochimie899113344
- 24. Ueda S, Kataoka T, Satoh T (2008) Activation of the small GTPase Rac1 by a specific guanine-nucleotide-exchange factor suffices to induce glucose uptake into skeletal-muscle cells. Biol Cell 100(11): 645–57.S. UedaT. KataokaT. Satoh2008Activation of the small GTPase Rac1 by a specific guanine-nucleotide-exchange factor suffices to induce glucose uptake into skeletal-muscle cells.Biol Cell1001164557
- 25. Kraynov VS, Chamberlain C, Bokoch GM, Schwartz MA, Slabaugh S, et al. (2000) Localized Rac activation dynamics visualized in living cells. Science 290(5490): 333–7.VS KraynovC. ChamberlainGM BokochMA SchwartzS. Slabaugh2000Localized Rac activation dynamics visualized in living cells.Science29054903337
- 26. Machacek M, Hodgson L, Welch C, Elliott H, Pertz O, et al. (2009) Coordination of Rho GTPase activities during cell protrusion. Nature 461(7260): 99–103.M. MachacekL. HodgsonC. WelchH. ElliottO. Pertz2009Coordination of Rho GTPase activities during cell protrusion.Nature461726099103
- 27. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, et al. (2003) Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161(5): 933–44.P. ChiarugiG. PaniE. GiannoniL. TaddeiR. Colavitti2003Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion.J Cell Biol161593344
- 28. Nimnual AS, Taylor LJ, Bar-Sagi D (2003) Redox-dependent downregulation of Rho by Rac. Nat Cell Biol 5: 236–41.AS NimnualLJ TaylorD. Bar-Sagi2003Redox-dependent downregulation of Rho by Rac.Nat Cell Biol523641
- 29. Wu RF, Xu YC, Ma Z, Nwariaku FE, Sarosi GA, et al. (2005) Subcellular targeting of oxidants during endothelial cell migration. J Cell Biol 171(5): 893–904.RF WuYC XuZ. MaFE NwariakuGA Sarosi2005Subcellular targeting of oxidants during endothelial cell migration.J Cell Biol1715893904
- 30. Shen E, Li Y, Li Y, Shan L, Zhu H, et al. (2009) Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes 58(10): 2386–95.E. ShenY. LiY. LiL. ShanH. Zhu2009Rac1 is required for cardiomyocyte apoptosis during hyperglycemia.Diabetes5810238695
- 31. Vecchione C, Aretini A, Marino G, Bettarini U, Poulet R, et al. (2006) Selective Rac-1 inhibition protects from diabetes-induced vascular injury. Circ Res 98(2): 218–25.C. VecchioneA. AretiniG. MarinoU. BettariniR. Poulet2006Selective Rac-1 inhibition protects from diabetes-induced vascular injury.Circ Res98221825
- 32. Li J, Zhu H, Shen E, Wan L, Arnold JM, et al. (2010) Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes. Diabetes 59(8): 2033–42.J. LiH. ZhuE. ShenL. WanJM Arnold2010Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes.Diabetes598203342
- 33. Pankov R, Endo Y, Even-Ram S, Araki M, Clark K, et al. (2005) A Rac switch regulates random versus directionally persistent cell migration. J Cell Biol 170: 793–802.R. PankovY. EndoS. Even-RamM. ArakiK. Clark2005A Rac switch regulates random versus directionally persistent cell migration.J Cell Biol170793802
- 34. Riveline D, Zamir E, Balaban NQ, Schwarz US, Ishizaki T, et al. (2001) Focal contacts as mechanosensors: externally applied local mechanical force induces growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. J Cell Biol 153(6): 1175–86.D. RivelineE. ZamirNQ BalabanUS SchwarzT. Ishizaki2001Focal contacts as mechanosensors: externally applied local mechanical force induces growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism.J Cell Biol1536117586
- 35. Peng F, Wu D, Gao B, Ingram AJ, Zhang B, et al. (2008) RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes 57: 1683–92.F. PengD. WuB. GaoAJ IngramB. Zhang2008RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.Diabetes57168392
- 36. Kolavennu V, Zeng L, Peng H, Wang Y, Danesh FR (2008) Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 57: 714–23.V. KolavennuL. ZengH. PengY. WangFR Danesh2008Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.Diabetes5771423
- 37. Shiga N, Hirano K, Hirano M, Nishimura J, Nawata H, et al. (2005) Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery. Circ Res 96: 1014–21.N. ShigaK. HiranoM. HiranoJ. NishimuraH. Nawata2005Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery.Circ Res96101421
- 38. Tang J, Kusaka I, Massey AR, Rollins S, Zhang JH (2006) Increased RhoA translocation in aorta of diabetic rats. Acta Pharmacol Sin 27: 543–8.J. TangI. KusakaAR MasseyS. RollinsJH Zhang2006Increased RhoA translocation in aorta of diabetic rats.Acta Pharmacol Sin275438
- 39. Lin G, Craig GP, Zhang L, Yuen VG, Allard M, et al. (2007) Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats. Cardiovasc Res 75: 51–8.G. LinGP CraigL. ZhangVG YuenM. Allard2007Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats.Cardiovasc Res75518
- 40. Liu L, Luo Y, Chen L, Shen T, Xu B, et al. (2010) Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity. J Biol Chem 285: 38362–73.L. LiuY. LuoL. ChenT. ShenB. Xu2010Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity.J Biol Chem2853836273
- 41. Demidenko ZN, Shtutman M, Blagosklonny MV (2009) Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence. Cell Cycle 15: 1896–900.ZN DemidenkoM. ShtutmanMV Blagosklonny2009Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence.Cell Cycle151896900
- 42. Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, et al. (2010) The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging 2: 344–52.LG KorotchkinaOV LeontievaEI BukreevaZN DemidenkoAV Gudkov2010The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.Aging234452
- 43. Demidenko ZN, Blagosklonny MV (2009) Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential. Aging 31: 1008–16.ZN DemidenkoMV Blagosklonny2009Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential.Aging31100816
- 44. Pani G (2010) P66SHC and ageing: ROS and TOR? Aging 2: 514–8.G. Pani2010P66SHC and ageing: ROS and TOR?Aging25148
- 45. Pan Y, Shadel GS (2009) Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density. Aging 28: 131–45.Y. PanGS Shadel2009Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density.Aging2813145
- 46. Glaven JA, Whitehead I, Bagrodia S, Kay R, Cerione RA (1999) The Dbl-related protein, Lfc, localizes to microtubules and mediates the activation of Rac signaling pathways in cells. J Biol Chem 274(4): 2279–85.JA GlavenI. WhiteheadS. BagrodiaR. KayRA Cerione1999The Dbl-related protein, Lfc, localizes to microtubules and mediates the activation of Rac signaling pathways in cells.J Biol Chem2744227985